Abstract 2050P
Background
Anorexia is the fourth common symptom seen in half of newly diagnosed cancer patients. It also remains most prevalent and troublesome clinical problem experienced by patients with cancer during and after chemotherapy. Consequently, anorexia adversely influences nutritional status of a patient which further causes a negative impact on quality of life and survival. Various herbs have shown to be having positive effect on treating anorexia. In this study, we analysed the effect of an Ayurveda formulation consisting standardised dry powders of 5 herbs indicated in Ayurveda for treatment of Anorexia.
Methods
We did an assessment of study variables related to anorexia, cachexia and quality of life in a heterogeneous group of stage IV cancer patients (n=45) receiving conventional therapies for cancer and complaining of anorexia. These patients were administered herbal capsule “Ruchir” for treatment of Anorexia. Ruchir is consisting dry herbal powders of Pomegranate (Punica grantum), Black pepper (Piper nigrum), Ginger (Zingiber officinale), Amla (Phyllanthus emblica), Cumin (Cuminum cyminum). Therapy response on Anorexia was assessed using AC (Anorexia/cachexia subscale) and its impact on quality of life was assessed using Functional Assessment of Anorexia / Cachexia Treatment (FAACT). Weight was recorded at each visit (day 0, day 30, day 90, and day 180) using digital weighing scale. Statistical significance was assessed using nonparametric Wilcoxon Signed Ranks Test.
Results
The mean age of study participants were 64.54 (±5.6) years. Significant improvement was observed in Anorexia sub scale score (P < 0.01) and quality of life (P<0.05) as compared to baseline. No significant change was observed in weight. Treatment was well tolerated by all patients.
Conclusions
Herbs used in this study have been shown to have significant effects in reducing anorexia and improving quality of life in a heterogeneous group of cancer patients. This study provides preliminary evidence about effectiveness of herbs in treating Anorexia in cancer patients. Further controlled studies in a homogenous group of patients are warranted to integrate herbs with a standard of care in cancer patients for management of Anorexia.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
Y.N. Bendale: Other, Personal, Ownership Interest: Rasayu Cancer Clinic. All other authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06
2055P - Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU
Presenter: Francisco Javier Ros Montana
Session: Poster session 06